Oncternal Therapeutics, Inc. (ONCT)
USD 0.53
(-24.12%)
USD 0.53
(-24.12%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 785 Thousand | 1.49 Million | 4.31 Million | 3.37 Million | 2.42 Million | 2.52 Million |
| Cost of Revenue | 29.75 Million | 179 Thousand | 169 Thousand | 12 Million | 10.15 Million | 46 Thousand |
| Gross Profit | -28.96 Million | 1.31 Million | 4.14 Million | -8.62 Million | -7.73 Million | 2.47 Million |
| Operating Expenses | 12.74 Million | 44.94 Million | 31.36 Million | 17.54 Million | 15.02 Million | 39.05 Million |
| Selling, General and Administrative Expenses | 12.74 Million | 13.45 Million | 11.59 Million | 8.37 Million | 7.28 Million | 9.39 Million |
| Research and Development Expenses | 29.75 Million | 32.98 Million | 24.08 Million | 12.54 Million | 10.15 Million | 29.66 Million |
| Other Expenses | -29.75 Million | -1.49 Million | -4.31 Million | -3.37 Million | -2.42 Million | 641 Thousand |
| Cost and Expenses | 42.49 Million | 44.94 Million | 31.36 Million | 17.54 Million | 15.02 Million | 39.05 Million |
| Operating Income | -41.71 Million | -44.94 Million | -31.36 Million | -17.54 Million | -33.1 Million | -39.05 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | -777 Thousand | -33 Thousand | -16 Thousand | -18.27 Million | 641 Thousand |
| Earnings before Tax | -39.47 Million | -44.17 Million | -31.33 Million | -17.22 Million | -34.18 Million | -38.41 Million |
| Net Income | -39.47 Million | -43.39 Million | -31.3 Million | -17.2 Million | -15.91 Million | -38.41 Million |
| Earnings Per Share Basic | -13.43 | -16.50 | -12.69 | -16.95 | -30.81 | -11.52 |
| Earnings Per Share Diluted | -13.43 | -16.50 | -12.69 | -16.95 | -30.81 | -11.52 |
| Weighted Average Shares Outstanding | 2.94 Million | 2.62 Million | 2.46 Million | 1.01 Million | 516.44 Thousand | 3.33 Million |
| Weighted Average Shares Outstanding (Diluted) | 2.94 Million | 2.62 Million | 2.46 Million | 1.01 Million | 516.44 Thousand | 3.33 Million |
| Gross Margin | -36.90 | 0.88 | 0.96 | -2.56 | -3.19 | 0.98 |
| EBIT Margin | 2.85 | -30.17 | -7.27 | -5.20 | -6.12 | -15.48 |
| Profit Margin | -50.29 | -29.12 | -7.25 | -5.10 | -6.56 | -15.24 |
| EBITDA | 2.23 Million | -44.94 Million | -31.36 Million | -17.54 Million | -33.1 Million | 1 Million |
| Earnings Before Tax Margin | -53.14 | -30.17 | -7.27 | -5.20 | -13.65 | -15.49 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 801 Thousand | 569 Thousand | 785 Thousand | 297 Thousand | 179 Thousand | 106 Thousand |
| Cost of Revenue | 5.9 Million | 6.05 Million | 29.75 Million | 6.67 Million | 75 Thousand | 37 Thousand |
| Gross Profit | -5.1 Million | -5.49 Million | -28.96 Million | -6.37 Million | 104 Thousand | 69 Thousand |
| Operating Expenses | 9.66 Million | 9.34 Million | 42.49 Million | 9.93 Million | 10.39 Million | 9.54 Million |
| Selling, General and Administrative Expenses | 3.05 Million | 3.28 Million | - | 3.26 Million | 3.09 Million | 3.07 Million |
| Research and Development Expenses | 6.61 Million | 6.05 Million | - | 6.67 Million | 7.47 Million | 6.57 Million |
| Other Expenses | -5.9 Million | - | - | 203 Thousand | - | - |
| Cost and Expenses | 9.66 Million | 9.34 Million | 42.49 Million | 9.93 Million | 10.39 Million | 9.54 Million |
| Operating Income | -8.86 Million | -8.77 Million | -41.71 Million | -9.63 Million | -10.39 Million | -9.54 Million |
| Interest Expense | - | - | - | 8000.00 | - | - |
| Income Tax Expense | -8.86 Million | -8.77 Million | -41.71 Million | -9.63 Million | -75 Thousand | -37 Thousand |
| Earnings before Tax | -8.55 Million | -8.38 Million | -39.47 Million | -9.16 Million | -9.86 Million | -8.96 Million |
| Net Income | -8.55 Million | -8.38 Million | -39.47 Million | -9.16 Million | -9.86 Million | -8.96 Million |
| Earnings Per Share Basic | -2.89 | -2.83 | - | -3.11 | -3.35 | -3.05 |
| Earnings Per Share Diluted | -2.89 | -2.83 | - | -3.11 | -3.35 | -3.05 |
| Weighted Average Shares Outstanding | 2.96 Million | 2.95 Million | 2.94 Million | 2.94 Million | 2.94 Million | 2.93 Million |
| Weighted Average Shares Outstanding (Diluted) | 2.96 Million | 2.95 Million | 2.94 Million | 2.94 Million | 2.94 Million | 2.93 Million |
| Gross Margin | -6.37 | -9.65 | -36.90 | -21.46 | 0.58 | 0.65 |
| EBIT Margin | -11.06 | -15.43 | - | -32.44 | -58.04 | -90.05 |
| Profit Margin | -10.69 | -14.74 | -50.29 | -30.86 | -55.09 | -84.58 |
| EBITDA | -8.86 Million | -8.77 Million | - | -9.63 Million | -10.39 Million | -9.54 Million |
| Earnings Before Tax Margin | -11.06 | -15.43 | -53.14 | -32.44 | -58.04 | -90.05 |
600596
DRL
2876
PNGAY
NBN
SF-PC